Equillium, Inc.EQNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-20.8%
5Y CAGR-0.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-20.8%/yr
vs +66.0%/yr prior
5Y CAGR
-0.8%/yr
Recent deceleration
Acceleration
-86.9pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$18.62M-50.2%
2024$37.43M+1.1%
2023$37.04M-1.4%
2022$37.55M+42.3%
2021$26.38M+36.1%
2020$19.38M+9.9%
2019$17.64M+256.9%
2018$4.94M+270.6%
2017$1.33M-